Barristers

The funder that's backing a class action over land compulsorily acquired for Sydney's WestConnex road project has filed an application to substitute the lead applicants, amid an ongoing fight about whether the case should be discontinued. 

The Full Court has found that a pleading error in an underpayments class action against The Reject Shop which left it empty of group members can be fixed but that the amended pleading cannot be backdated.

A 27-year old cricketer who will be permanently bound to a wheelchair has won a $15.2 million judgment against a local council over its failure to install pedestrian gates at a convenient location near the cricket grounds, with a judge finding this led to players routinely jumping a fence to exit. 

Mastercard made ‘strategic’ agreements with large retailers like Coles and David Jones to keep them from routing through EFTPOS, offering discounted exchange rates that left smaller businesses footing the bill, the ACCC told the court on the first day of trial.

The chair of airport operator APAC has admitted redacting advice from Herbert Smith Freehills Kramer to remove a suggested remedy for major shareholder Dexus' alleged breach of confidentiality, but denies she misled the board.

A top in-house lawyer at Dexus has told a court the real estate asset manager was using an altered form of a non-disclosure agreement with bidders of a portion of its APAC bloc of shares without the approval of the airport operator's co-owners.

In the first shareholder class action to succeed at trial in Australia, a judge has found logistics chain company Brambles breached its continuous disclosure obligations in relation to an overly rosy 2017 financial forecast amid problems with its North American pallets business.

The High Court has agreed to review a ruling that upheld an easement of prescription -- or right of long use -- in a fight between a member of the prominent Valmorbida family and an entity linked to the founder of collapsed construction group Steller over access to a Sorrento property.

AstraZeneca can inspect Pharmacor's emails to verify its claim that the merits of its challenge to a patent extension for blockbuster diabetes drug Forxiga were not appreciated at an earlier time, with a judge finding Pharmacor had waived privilege. 

The court battle between APAC and major shareholder Dexus over the sale of an investor's stake in the airport operator went to a hearing this week, but it's the solicitors representing the warring parties that found themselves on trial.